Tekla Capital Management LLC current holdings: USA Other Stocks
Tekla Capital Management LLC reported $0.55 billion in shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), 48 positions, in its Form 13F for the quarter ended 2016-09-30; the largest are Celgene Corporation, Allergan plc, Alexion Pharmaceuticals, Inc..
- Celgene Corporation: Country of operation —; Class Common; Shares 1,484,089; Value $155,132,000.
- Allergan plc: Country of operation —; Class Common; Shares 434,086; Value $99,974,000.
- Alexion Pharmaceuticals, Inc.: Country of operation —; Class Common; Shares 764,005; Value $93,621,000.
- The Medicines Company: Country of operation —; Class Common; Shares 564,438; Value $21,302,000.
Form 13F-HR as filed (SEC CIK 1300336): quarter ended 2016-09-30, filed 2016-11-14. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.
| Stock | Country of operation | Class | Shares | Value | Quarter end | Filed |
|---|
Celgene Corporation
CUSIP 151020104 | | Common | 1,484,089 | $155,132,000 | 2016-09-30 | 2016-11-14 |
|---|
Allergan plc
CUSIP G0177J108 | | Common | 434,086 | $99,974,000 | 2016-09-30 | 2016-11-14 |
|---|
Alexion Pharmaceuticals, Inc.
CUSIP 015351109 | | Common | 764,005 | $93,621,000 | 2016-09-30 | 2016-11-14 |
|---|
The Medicines Company
CUSIP 584688105 | | Common | 564,438 | $21,302,000 | 2016-09-30 | 2016-11-14 |
|---|
Cepheid, Inc.
CUSIP 15670R107 | | Common | 333,590 | $17,577,000 | 2016-09-30 | 2016-11-14 |
|---|
Physicians Realty Trust
CUSIP 71943U104 | United States | Common | 530,672 | $11,431,000 | 2016-09-30 | 2016-11-14 |
|---|
Cigna Corporation
CUSIP 125509109 | | Common | 86,400 | $11,260,000 | 2016-09-30 | 2016-11-14 |
|---|
Paratek Pharmaceuticals, Inc.
CUSIP 699374302 | United States | Common | 762,581 | $9,921,000 | 2016-09-30 | 2016-11-14 |
|---|
Endologix, Inc.
CUSIP 29266S106 | | Common | 773,500 | $9,901,000 | 2016-09-30 | 2016-11-14 |
|---|
Pieris Pharmaceuticals, Inc.
CUSIP 720795103 | | Common | 4,145,958 | $7,587,000 | 2016-09-30 | 2016-11-14 |
|---|
Retrophin, Inc.
CUSIP 761299106 | | Common | 329,949 | $7,384,000 | 2016-09-30 | 2016-11-14 |
|---|
ARIAD Pharmaceuticals, Inc.
CUSIP 04033A100 | | Common | 502,000 | $6,872,000 | 2016-09-30 | 2016-11-14 |
|---|
Sage Therapeutics, Inc.
CUSIP 78667J108 | United States | Common | 146,800 | $6,760,000 | 2016-09-30 | 2016-11-14 |
|---|
PRA Health Sciences, Inc.
CUSIP 69354M108 | | Common | 102,000 | $5,764,000 | 2016-09-30 | 2016-11-14 |
|---|
Juno Therapeutics, Inc.
CUSIP 48205A109 | | Common | 182,000 | $5,462,000 | 2016-09-30 | 2016-11-14 |
|---|
Vitae Pharmaceuticals, Inc.
CUSIP 92847N103 | | Common | 250,000 | $5,230,000 | 2016-09-30 | 2016-11-14 |
|---|
Depomed, Inc.
CUSIP 249908104 | | Common | 200,000 | $4,998,000 | 2016-09-30 | 2016-11-14 |
|---|
New Senior Investment Group Inc.
CUSIP 648691103 | | Common | 430,997 | $4,974,000 | 2016-09-30 | 2016-11-14 |
|---|
Karyopharm Therapeutics, Inc.
CUSIP 48576U106 | United States | Common | 500,324 | $4,868,000 | 2016-09-30 | 2016-11-14 |
|---|
Valeant Pharmaceuticals International, Inc.
CUSIP 91911K102 | | Common | 192,000 | $4,714,000 | 2016-09-30 | 2016-11-14 |
|---|
Akorn, Inc.
CUSIP 009728106 | | Common | 145,235 | $3,959,000 | 2016-09-30 | 2016-11-14 |
|---|
Epizyme, Inc.
CUSIP 29428V104 | | Common | 400,000 | $3,936,000 | 2016-09-30 | 2016-11-14 |
|---|
bluebird bio, Inc.
CUSIP 09609G100 | United States | Common | 49,345 | $3,345,000 | 2016-09-30 | 2016-11-14 |
|---|
Accelerate Diagnostics, Inc.
CUSIP 00430H102 | | Common | 120,000 | $3,271,000 | 2016-09-30 | 2016-11-14 |
|---|
Impax Laboratories, Inc.
CUSIP 45256B101 | | Common | 124,335 | $2,947,000 | 2016-09-30 | 2016-11-14 |
|---|
Global Blood Therapeutics, Inc.
CUSIP 37890U108 | | Common | 125,000 | $2,881,000 | 2016-09-30 | 2016-11-14 |
|---|
Dermira, Inc.
CUSIP 24983L104 | | Common | 82,600 | $2,794,000 | 2016-09-30 | 2016-11-14 |
|---|
Nevro Corp.
CUSIP 64157F103 | United States | Common | 25,000 | $2,610,000 | 2016-09-30 | 2016-11-14 |
|---|
Diplomat Pharmacy, Inc.
CUSIP 25456K101 | | Common | 87,163 | $2,441,000 | 2016-09-30 | 2016-11-14 |
|---|
ARCA biopharma, Inc.
CUSIP 00211Y407 | | Common | 811,227 | $2,344,000 | 2016-09-30 | 2016-11-14 |
|---|
TherapeuticsMD, Inc.
CUSIP 88338N107 | | Common | 307,000 | $2,091,000 | 2016-09-30 | 2016-11-14 |
|---|
Flex Pharma, Inc.
CUSIP 33938A105 | | Common | 162,124 | $1,910,000 | 2016-09-30 | 2016-11-14 |
|---|
Merrimack Pharmaceuticals, Inc.
CUSIP 590328100 | | Common | 286,000 | $1,816,000 | 2016-09-30 | 2016-11-14 |
|---|
Momenta Pharmaceuticals, Inc.
CUSIP 60877T100 | | Common | 153,700 | $1,797,000 | 2016-09-30 | 2016-11-14 |
|---|
Inotek Pharmaceuticals Corporation
CUSIP 45780V102 | | Common | 180,762 | $1,714,000 | 2016-09-30 | 2016-11-14 |
|---|
Chimerix, Inc.
CUSIP 16934W106 | United States | Common | 308,892 | $1,711,000 | 2016-09-30 | 2016-11-14 |
|---|
Cidara Therapeutics, Inc.
CUSIP 171757107 | | Common | 132,472 | $1,517,000 | 2016-09-30 | 2016-11-14 |
|---|
Auris Medical Holding AG
CUSIP H03579101 | | Common | 774,504 | $1,340,000 | 2016-09-30 | 2016-11-14 |
|---|
Alliqua BioMedical, Inc.
CUSIP 019621200 | | Common | 1,650,000 | $1,287,000 | 2016-09-30 | 2016-11-14 |
|---|
Revance Therapeutics, Inc.
CUSIP 761330109 | United States | Common | 75,000 | $1,216,000 | 2016-09-30 | 2016-11-14 |
|---|
Bellicum Pharmaceuticals, Inc.
CUSIP 079481107 | | Common | 60,000 | $1,194,000 | 2016-09-30 | 2016-11-14 |
|---|
Novavax, Inc.
CUSIP 670002104 | | Common | 571,000 | $1,188,000 | 2016-09-30 | 2016-11-14 |
|---|
GenMark Diagnostics, Inc.
CUSIP 372309104 | | Common | 93,349 | $1,102,000 | 2016-09-30 | 2016-11-14 |
|---|
Affimed NV
CUSIP N01045108 | United States | Common | 294,213 | $818,000 | 2016-09-30 | 2016-11-14 |
|---|
Tetraphase Pharmaceuticals Inc.
CUSIP 88165N105 | | Common | 192,322 | $737,000 | 2016-09-30 | 2016-11-14 |
|---|
Quorum Health Corporation
CUSIP 74909E106 | | Common | 76,118 | $477,000 | 2016-09-30 | 2016-11-14 |
|---|
Celldex Therapeutics, Inc.
CUSIP 15117B103 | | Common | 105,800 | $427,000 | 2016-09-30 | 2016-11-14 |
|---|
Zafgen, Inc.
CUSIP 98885E103 | | Common | 13,307 | $44,000 | 2016-09-30 | 2016-11-14 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |